Please login to the form below

Not currently logged in
Email:
Password:

EMD Serono president James Hoyes joins consultants RxC

Takes up a role as executive partner at the US management consulting firm

RxC International EMD Serono James HoyesJames Hoyes has joined RxC International as an executive partner, having worked for the New Jersey management consulting firm as a senior advisor since 2014.

He was previously president of EMD Serono - as the US biopharma operations of Germany's Merck are known - having initially joined the company in 2004 as VP of neurology marketing.

Hoyes subsequently held roles as executive vice president, managing EMD Serono's neurology sales, marketing, comms, call centre and medical affairs operations, and as chief commercial officer.

Prior to joining EMD Serono, Hoyes held leadership positions with the likes of Serono, Elan and Sanofi.

In his new consultancy role he will provide advisory services to RxC's clients, work on corporate development initiatives in life sciences and implement key strategic initiatives to scale up the firm's global operations.

RxC International managing partner Subbarao Jayanthi said: “Jim's addition represents another milestone in the expansion of our business. He has an outstanding track record as a leader in the life sciences sector, and his deep strategic and executive leadership expertise will be invaluable to our clients.”

12th August 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Planning your clinical trial? Why you need to engage patients sooner
It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI and life sciences
AI: the smart money is on the smart thinking
Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...

Infographics